Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Type 2 Diabetes”

444 trials

Showing 20 of 444 results

Early research (Phase 1)Study completedNCT00404963
What this trial is testing

Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Who this might be right for
Type 2 Diabetes Mellitus
GlaxoSmithKline 72
Very early researchStudy completedNCT03479671
What this trial is testing

Low Dose Fat-Induced Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceInsulin Sensitivity
University of Pennsylvania 9
Early research (Phase 1)Study completedNCT04513704
What this trial is testing

A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

Who this might be right for
Healthy Volunteers Type 2 Diabetes
Novo Nordisk A/S 156
Early research (Phase 1)Study completedNCT01240980
What this trial is testing

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Who this might be right for
Diabetes
Bristol-Myers Squibb 104
Early research (Phase 1)Study completedNCT03864432
What this trial is testing

An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)

Who this might be right for
Type 2 Diabetes Mellitus
LG Chem 48
Post-approval studies (Phase 4)UnknownNCT02587975
What this trial is testing

Effect of Evogliptin on Bone Metabolism in Human

Who this might be right for
Diabetes Mellitus, Type 2Osteoporosis
DongGuk University 20
Early research (Phase 1)Study completedNCT04586907
What this trial is testing

LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Who this might be right for
HealthyType 2 Diabetes Mellitus
Eli Lilly and Company 85
Not applicableStudy completedNCT03771781
What this trial is testing

Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.

Who this might be right for
Type 2 Diabetes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 48
Early research (Phase 1)Looking for participantsNCT06945406
What this trial is testing

LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 124
Early research (Phase 1)Looking for participantsNCT07455825
What this trial is testing

Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Who this might be right for
Healthy Participants
AstraZeneca 64
Early research (Phase 1)Study completedNCT00790153
What this trial is testing

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Who this might be right for
Type 2 Diabetes
AstraZeneca 12
Early research (Phase 1)UnknownNCT03849495
What this trial is testing

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

Who this might be right for
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT01919684
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ligand Pharmaceuticals 56
Early research (Phase 1)Looking for participantsNCT06829563
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D

Who this might be right for
Diabetes
Rezubio Pharmaceuticals Co., Ltd. 134
Early research (Phase 1)Study completedNCT01301092
What this trial is testing

Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.

Who this might be right for
Diabetes Mellitus, Type II
Eli Lilly and Company 30
Early research (Phase 1)Study completedNCT01489644
What this trial is testing

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 62
Early research (Phase 1)Study completedNCT01972893
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Zydus Lifesciences Limited 56
Early research (Phase 1)Study completedNCT05409924
What this trial is testing

First-in-human Single and Multiple Dose Trial of ATR-258

Who this might be right for
Type 2 Diabetes Mellitus
Atrogi AB 71
Very early researchTemporarily pausedNCT06845943
What this trial is testing

A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes

Who this might be right for
Obesity and Overweight
Helicore Biopharma, Inc. 48
Early research (Phase 1)Study completedNCT06723691
What this trial is testing

Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 57
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation